Detalhe da pesquisa
1.
Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy.
Br J Cancer
; 129(11): 1766-1772, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813958
2.
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.
Future Oncol
; 19(34): 2277-2289, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746835
3.
Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.
Br J Cancer
; 126(5): 693-705, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663949
4.
Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary.
Br J Cancer
; 127(3): 531-540, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484217
5.
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer.
Br J Cancer
; 127(8): 1473-1478, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869145
6.
Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes.
Oncologist
; 27(2): 97-103, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641203
7.
Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy.
Acta Oncol
; 61(5): 583-590, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392758
8.
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
Oncologist
; 26(4): e669-e678, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210382
9.
Liver Embolisation for Patients with Neuroendocrine Neoplasms: Systematic Review.
Neuroendocrinology
; 111(4): 354-369, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32172229
10.
Molecular targeted therapies: Ready for "prime time" in biliary tract cancer.
J Hepatol
; 73(1): 170-185, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171892
11.
Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectives.
Curr Opin Oncol
; 32(4): 364-369, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541326
12.
Impact on prognosis of early weight loss during palliative chemotherapy in patients diagnosed with advanced pancreatic cancer.
Pancreatology
; 20(8): 1682-1688, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046391
13.
The assessment of pancreatic exocrine function in patients with inoperable pancreatic cancer: In need of a new gold-standard.
Pancreatology
; 20(4): 668-675, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32284260
14.
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine Neoplasms.
Neuroendocrinology
; 110(7-8): 688-696, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31639796
15.
18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis.
J Hepatol
; 71(1): 115-129, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30797051
16.
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas.
Neuroendocrinology
; 109(2): 100-112, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30703770
17.
Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
J Surg Oncol
; 119(7): 932-940, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30838647
18.
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
Cancer Metastasis Rev
; 36(1): 141-157, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27981460
19.
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.
Br J Cancer
; 119(1): 27-35, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925934
20.
Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
J Neurooncol
; 132(3): 463-471, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28332000